Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

A new prognostic strategy for gastric carcinoma: albumin level and metastatic lymph node ratio.

Isik A, Okan I, Firat D, Yilmaz B, Akcakaya A, Sahin M.

Minerva Chir. 2014 Jun;69(3):147-53.

PMID:
24970303
2.

Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.

Alatengbaolide, Lin D, Li Y, Xu H, Chen J, Wang B, Liu C, Lu P.

Am J Clin Oncol. 2013 Aug;36(4):325-30. doi: 10.1097/COC.0b013e318246b4e9.

PMID:
22547011
3.

Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma.

Cheong O, Oh ST, Kim BS, Yook JH, Kim JH, Im JT, Park GC.

World J Surg. 2008 Feb;32(2):262-6.

PMID:
18064519
4.

Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.

Bilici A, Seker M, Ustaalioglu BB, Yilmaz B, Doventas A, Salepci T, Gumus M.

Med Oncol. 2010 Sep;27(3):975-84. doi: 10.1007/s12032-009-9319-4. Epub 2009 Nov 3.

PMID:
19885750
5.

Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.

Wu XJ, Miao RL, Li ZY, Bu ZD, Zhang LH, Wu AW, Zong XL, Li SX, Shan F, Ji X, Ren H, Ji JF.

Eur J Surg Oncol. 2015 Jul;41(7):927-33. doi: 10.1016/j.ejso.2015.03.225. Epub 2015 Apr 3.

PMID:
25913059
6.

Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer.

Espín F, Bianchi A, Llorca S, Feliu J, Palomera E, García O, Remon J, Suñol X.

Eur J Surg Oncol. 2012 Jun;38(6):497-502. doi: 10.1016/j.ejso.2012.01.012. Epub 2012 Mar 23.

PMID:
22445061
7.

Lymphatic involvement in early gastric cancer: prevalence and prognosis in France.

Borie F, Millat B, Fingerhut A, Hay JM, Fagniez PL, De Saxce B.

Arch Surg. 2000 Oct;135(10):1218-23.

PMID:
11030885
8.

The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.

Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Di Leo A, Marrelli D, Roviello F, Morgagni P, Saragoni L, Natalini G, De Santis F, Baiocchi L, Coniglio A, Nitti D; Italian Research Group for Gastric Cancer Study (GIRCG)..

Eur J Surg Oncol. 2008 Feb;34(2):159-65. Epub 2007 Jun 13.

PMID:
17566691
9.

[Prognostic value of metastatic lymph node ratio in gastric cancer].

A La-teng BL, Li YM, Liu CG, Wang BB, Xu HM, Chen JQ, Wang SB, Lu P.

Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Feb;15(2):137-40. Chinese.

PMID:
22368019
10.

Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.

Saito H, Fukumoto Y, Osaki T, Yamada Y, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M.

J Surg Oncol. 2008 Feb 1;97(2):132-5.

PMID:
17979134
11.

The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.

Fukagawa T, Sasako M, Shimoda T, Sano T, Katai H, Saka M, Mann GB, Karpeh M, Coit DG, Brennan MF.

Ann Surg Oncol. 2009 Mar;16(3):609-13. doi: 10.1245/s10434-008-0290-7. Epub 2009 Jan 10.

PMID:
19137375
12.

Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer.

Polterauer S, Khalil S, Zivanovic O, Abu-Rustum NR, Hofstetter G, Concin N, Grimm C, Reinthaller A, Barakat RR, Leitao MM Jr.

Obstet Gynecol. 2012 Jun;119(6):1210-8. doi: 10.1097/AOG.0b013e318255060c.

PMID:
22617586
13.

Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer.

Zhang BY, Yuan J, Cui ZS, Li ZW, Li XH, Lu YY.

Am J Surg. 2014 Apr;207(4):555-65. doi: 10.1016/j.amjsurg.2013.05.004. Epub 2013 Oct 12.

PMID:
24124661
14.

Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.

Martinez-Ramos D, Calero A, Escrig-Sos J, Mingol F, Daroca-Jose JM, Sauri M, Arroyo A, Salvador-Sanchis JL, de Juan M, Calpena R, Lacueva FJ.

Eur J Surg Oncol. 2014 Mar;40(3):358-65. doi: 10.1016/j.ejso.2013.08.027. Epub 2013 Sep 8.

PMID:
24075824
15.

Prognostic significance of metastatic lymph node ratio in T3 gastric cancer.

Hyung WJ, Noh SH, Yoo CH, Huh JH, Shin DW, Lah KH, Lee JH, Choi SH, Min JS.

World J Surg. 2002 Mar;26(3):323-9. Epub 2001 Dec 21.

PMID:
11865369
16.

The prognostic analysis of lymph node-positive gastric cancer patients following curative resection.

Deng J, Liang H, Sun D, Pan Y.

J Surg Res. 2010 Jun 1;161(1):47-53. doi: 10.1016/j.jss.2008.12.019. Epub 2009 Jan 10.

PMID:
19783008
17.

Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer.

Dutta S, Crumley AB, Fullarton GM, Horgan PG, McMillan DC.

Am J Surg. 2012 Sep;204(3):294-9. doi: 10.1016/j.amjsurg.2011.10.015. Epub 2012 Mar 22.

PMID:
22444831
18.

[Comparison of the prognostic value of UICC and JGCA lymph node staging criteria for gastric cancer].

Pan Y, Liang H, Xue Q, Zhang RP, Cui QH, Liu N, Wang BG.

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):376-80. Chinese.

PMID:
18953840
19.

Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer.

Son T, Hyung WJ, Lee JH, Kim YM, Kim HI, An JY, Cheong JH, Noh SH.

Cancer. 2012 Oct 1;118(19):4687-93. doi: 10.1002/cncr.27426. Epub 2012 Mar 13.

20.

Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.

Asoglu O, Karanlik H, Parlak M, Kecer M, Muslumanoglu M, Igci A, Ozmen V, Gulluoglu M, Kapran Y.

Hepatogastroenterology. 2009 May-Jun;56(91-92):908-13.

PMID:
19621727

Supplemental Content

Support Center